Summary:
The cell reaction to chemotherapy is based on certain general biological principles. The genetic structure of cell
populations, their actual reaction to chemotherapy and the prognosis of their development are not accidental. They
are determined by previous exposures to chemotherapeutic agents and thus their evolutional experience on Darwinian
principles. Chemotherapy occurs always in a defined environment of the host with his active participation. A genetic
variability in the host reaction to chemotherapeutic interference also exists and which in the long-term perspective
is also of evolutional nature. The complex of evaluation of therapeutic procedures thus involves evaluation and
influencing of the host and his variability (immunotherapy). Understanding of molecular mechanisms of the
pathogenesis of disease, definition of specific genes, their expression, the role of their products and definition of
possible targets of chemotherapy is at present a realistic goal of application of genomics and proteogenomics in
medicine. The new philosophy in medicine is thus based on respecting individuality in diagnosis, treatment and
prognosis. We only can wish that the trend of respecting individuality will be applied in the future, and not only in
medicine.
Key words:
chemotherapy, avolution, resistance, infectious diseases, immunosuppresion, viruses, bacteria, host,
polymorphism, main histocompatibility system (MHC).
|